Clinical Inquiries: Does breastfeeding affect the risk of childhood obesity?

Lindsay Gunnell1, Jon Neher1, Sarah Safranek2

  • 1Valley Family Medicine Residency, University of Washington at Renton, WA, USA.

Insights

Breastfeeding reduces overweight and obesity risk. Ever breastfeeding lowers risk by 15%, while exclusive breastfeeding for 6 months offers a 30-50% reduction.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutrition Science

Background:

  • Childhood overweight and obesity are significant public health concerns.
  • Breastfeeding is recognized for its numerous health benefits for infants and mothers.
  • Understanding the long-term impact of breastfeeding on weight status is crucial for health policy.

Purpose of the Study:

  • To investigate the association between breastfeeding and the risk of developing overweight or obesity later in childhood.
  • To quantify the risk reduction associated with different durations and exclusivity of breastfeeding.

Main Methods:

  • Longitudinal study design tracking children's weight status over time.
  • Comparison between children who were breastfed and those who were never breastfed.
  • Statistical analysis to determine the relative risk of overweight/obesity based on breastfeeding history.

Main Results:

  • Ever having breastfed was associated with a 15% lower risk of overweight or obesity.
  • Exclusive breastfeeding for 6 months showed a substantial risk reduction of 30% to 50% compared to never breastfeeding.
  • The protective effect of breastfeeding on weight status persisted over a follow-up period of 2 to 14 years.

Conclusions:

  • Breastfeeding, particularly exclusive breastfeeding for at least 6 months, is a significant protective factor against childhood overweight and obesity.
  • Promoting and supporting breastfeeding can be an effective public health strategy for combating the obesity epidemic.
  • Long-term health benefits underscore the importance of breastfeeding initiation and duration.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
89.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
335
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K